Literature DB >> 5130534

Stability of prothrombin and factor VII in freeze-dried plasma.

M Brozović, L J Gurd, I Robertson, D R Bangham.   

Abstract

The stability of prothrombin and factor VII was studied using accelerated degradation tests in three preparations of freeze-dried pooled normal plasmas. In a previous report (Brozović, Gurd, Robertson, and Bangham, 1971) factor X was shown to be relatively unstable in these preparations of freeze-dried plasma: it was calculated that up to 8% of the original factor X activity would be lost after 10 years at -20 degrees C, up to 54% at 4 degrees C, and up to 90% at room temperature. The losses of factor VII activity were estimated to be negligible at -20 degrees C, between 2 and 18% at 4 degrees C, and between 20 and 70% of the original activity at 20 degrees C, after 10 years of storage. Prothrombin was found to be less stable than factor VII: the expected loss in 10 years at -20 degrees C may be up to 4%, at 4 degrees C up to 30%, and at 20 degrees C up to 83% of the initial activity. These findings indicate that in freeze-dried plasma prothrombin as well as factor X may be insufficiently stable for plasma to serve as long-term reference material for the standardization of the one-stage prothrombin time. Moreover, the loss of prothrombin and factor X in freeze-dried plasma stored at 4 degrees C may be so high that when it is required to preserve these factors it may be necessary to store freeze-dried plasma at lower temperatures.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5130534      PMCID: PMC477133          DOI: 10.1136/jcp.24.8.690

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  10 in total

1.  The stability of biological standards.

Authors:  N K JERNE; W L PERRY
Journal:  Bull World Health Organ       Date:  1956       Impact factor: 9.408

2.  Standardization of the one-stage prothrombin time test for the control of anticoagulant therapy: availability and use of thromboplastin reference preparations.

Authors:  R Biggs; D R Bangham
Journal:  Br Med J       Date:  1971-08

3.  Laboratory control of oral anticoagulants. Definition of therapeutic range in terms of different thromboplastin preparations.

Authors:  E A Loeliger; J B Meuwisse-Braun; H Muis; F J Buitendijk; J J Veltkamp; H C Hemker
Journal:  Thromb Diath Haemorrh       Date:  1970-06-30

4.  Validity of the British system for anticoagulant control using the national reagent.

Authors:  M R Alderson; L Poller; J M Thomson
Journal:  J Clin Pathol       Date:  1970-05       Impact factor: 3.411

5.  Preparation of quality control specimens for coagulation.

Authors:  S Zucker; M H Cathey; B West
Journal:  Am J Clin Pathol       Date:  1970-06       Impact factor: 2.493

6.  Prothrombin time standardization. Proposal of the Standards Committee, College of American Pathologists, Subcommittee on Coagulation Reagents.

Authors:  J B Miale; D LaFond
Journal:  Am J Clin Pathol       Date:  1969-08       Impact factor: 2.493

7.  The interpretation of prothrombin results: a national survey.

Authors:  L Poller; J M Thomson
Journal:  Br J Haematol       Date:  1969 Jan-Feb       Impact factor: 6.998

8.  Factor X in freeze-dried factor- VIII reference plasma.

Authors:  D R Bangham; I Robertson; L J Gurd; M Brozović
Journal:  Br J Haematol       Date:  1971-08       Impact factor: 6.998

9.  1963 prothrombin time test survey, College of American Pathologists, Standards Committee, Subcommittee on Coagulation.

Authors:  J B Miale; D J Lafond
Journal:  Am J Clin Pathol       Date:  1967-01       Impact factor: 2.493

10.  Standardization of the one-stage prothrombin time for the control of anticoagulant therapy.

Authors:  R Biggs; K W Denson
Journal:  Br Med J       Date:  1967-01-14
  10 in total
  3 in total

1.  Standardization of diagnostic materials. 3. Laboratory reagents and coagulation assay procedures.

Authors:  E A Loeliger
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

2.  Stability of freeze-dried plasma prepared from patients on oral anticoagulants.

Authors:  M Brozović; D J Howarth; L P van Halem Visser; E A Loeliger
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

3.  Thrombin generation in the Glasgow Myocardial Infarction Study.

Authors:  Machiel Smid; Arne W J H Dielis; Henri M H Spronk; Ann Rumley; Rene van Oerle; Mark Woodward; Hugo ten Cate; Gordon Lowe
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.